New Drug Doubles One-Year Survival in Pancreatic Cancer Trial
April 14, 2026
April 14, 2026
EVANSTON, Illinois, April 14 (TNSjou) -- Northwestern University posted the following news release:
* * *
New drug doubles one-year survival in pancreatic cancer trial
Phase 2 randomized trial shows 38% reduction in risk of death with the drug when combined with chemotherapy
*
Pancreatic cancer is one of the deadliest cancers and among the hardest to treat, with most patients surviving less than a year after diagnosis. But a new dr . . .
* * *
New drug doubles one-year survival in pancreatic cancer trial
Phase 2 randomized trial shows 38% reduction in risk of death with the drug when combined with chemotherapy
*
Pancreatic cancer is one of the deadliest cancers and among the hardest to treat, with most patients surviving less than a year after diagnosis. But a new dr . . .